MVE Biological Solutions, a Cryoport company, has launched new vapor shippers, the SC 4/2V and SC 4/3V, offering medical professionals, laboratories, researchers, hospitals and clinics, pharmaceutical companies, and others dramatically improved safety and reliability for transporting and preserving sensitive biological materials at cryogenic temperatures.

Built on MVE’s legacy SC 4/2V and 4/3V vapor shipper platform, the next-generation SC 4/2V and 4/3V models have been redesigned utilizing innovative technologies to offer customers added protection during extended or challenging shipments.

These four-liter vapor shippers are engineered to safely transport critical biological materials such as cells and tissues materials for cell therapies, biopharma, reproductive health materials, and animal health materials, including vaccines, while maintaining the materials’ integrity throughout the journey.

The new SC 4/2V and SC 4/3V vapor shipper models include several key advancements designed to enhance performance and reliability. Hold times for both next-generation models have been significantly extended to up to 19 days for the SC 4/2V (previously 13 days) and 26 days for the SC 4/3V (up from 21 days) which provides greater flexibility and security during transit delays. MVE’s patented BEND DON’T BREAK technology features a specially designed top that flexes under stress, absorbing impact to reduce the risk of damage during rough handling that sometimes happens during shipping.

“At MVE, we are committed to continuously refining our products to meet the evolving demands of our customers,” said Mike Duich, President and CEO of MVE Biological Solutions. “The new SC 4/2V and 4/3V vapor shippers, built on our proven and trusted platform, are now strengthened with longer hold times, reduced refill frequency and lower operating costs.”

Other upgraded features of the new vapor shippers include a newly integrated lid locking tab which helps prevent breakage, along with MVE’s patent-pending Vapor Shield Technology, which minimizes the risk of vacuum loss caused by liquid nitrogen overfilling. These enhancements work together to provide greater reliability when transporting critical biological materials.